Dog Skin Allergies: Apoquel and Steroids Work Differently

A randomized lab study in 16 beagles found that both oclacitinib (Apoquel) and prednisolone (a common steroid) reduced allergy-related gene activity in dog skin, but each drug targets different immune pathways — helping explain why treatment outcomes can vary.

Journal: Veterinary Sciences
Sample Size: 16 healthy research beagles
Study Type: Randomized experimental transcriptomic study
Published: 2026-07-13
Species:

Key Findings

  • Both drugs reduced many allergy-related gene-expression changes.
  • Prednisolone produced a broader inhibitory response.
  • The drugs affect different immune pathways.

If your dog has skin allergies, your vet has likely mentioned either Apoquel (the brand name for oclacitinib) or a steroid like prednisolone. Both are widely used to ease the itching and inflammation that come with dog skin allergies. But do they work the same way under the hood? A new study published in Veterinary Sciences looked at exactly that — and found that while both drugs calm allergy-related activity in dog skin, they each do it through different biological routes.

That difference may seem technical, but it has a real-world meaning: it helps explain why one dog might respond well to Apoquel while another does better on a steroid — and why your vet might switch a dog from one medication to the other.

Why Scientists Looked at Gene Activity

When a dog’s immune system reacts to something it’s allergic to — pollen, dust mites, certain foods — it triggers a cascade of chemical signals inside immune cells. These signals switch on specific genes, which then produce proteins that cause redness, swelling, and that relentless itch.

Researchers wanted to understand which of those gene signals each drug is quieting. Think of genes like light switches on a huge electrical panel. Both oclacitinib and prednisolone can dim many of those switches — but they may be reaching into different parts of the panel.

Understanding this matters because not every allergic dog is the same. Some respond well to one drug and not the other. Knowing which switches each drug controls could one day help vets choose the right medication the first time.

How the Study Was Designed

The researchers used a randomized experimental design with 16 healthy research beagles. This type of study — called a transcriptomic study (measuring which genes are switched on or off) — looks at changes in gene activity rather than clinical symptoms like scratching or hair loss.

Key study details:

  • Subjects: 16 healthy research beagles
  • Design: Randomized experimental; dogs were assigned to treatment groups
  • Drugs studied: Oclacitinib (Apoquel) and prednisolone (a commonly used steroid)
  • What was measured: Changes in the activity of allergy-related genes in the dogs’ skin
  • Goal: Compare how each drug affects the immune system’s gene-level response to allergic signals

Because the dogs were healthy, the researchers triggered allergy-like immune responses in a controlled setting and then measured how each drug changed the genetic activity compared to untreated responses.

What the Researchers Found

The central finding is that both drugs work — but not identically.

Both oclacitinib and prednisolone reduced many allergy-related gene-expression changes. In other words, each drug successfully turned down the genetic alarm bells that go off during an allergic skin response. This confirms that both medications are genuinely targeting immune activity, not just masking surface symptoms.

However, prednisolone produced a broader inhibitory response. The steroid quieted a wider range of genes involved in immune signaling. Oclacitinib was more targeted — it calmed specific pathways without suppressing as many different parts of the immune system.

Simply put: the steroid is like turning down an entire section of the electrical panel, while Apoquel is more like dimming a specific row of switches.

What This Means for Dogs on Allergy Medication

Why Your Dog’s Response May Differ From Another Dog’s

Because these two drugs are working through different mechanisms, a dog that does not respond well to one may still benefit from the other. The immune system is complicated, and the exact set of gene signals driving one dog’s itching may not be the same as another dog’s — even if both dogs look like they have the same allergy symptoms.

This research helps explain why vets sometimes try one medication and then switch to another if the first doesn’t work well enough. It’s not guesswork — there’s a biological reason why the drugs aren’t interchangeable for every dog.

If Your Dog’s Allergy Medication Isn’t Working

If your dog is on allergy medication that isn’t giving full relief, this study provides useful context for a conversation with your vet. Some questions worth raising:

  • “Could we try a different medication if this one isn’t giving full relief?”
  • “Is Apoquel or a steroid a better starting point for my dog’s specific type of allergy?”
  • “Are there signs I should watch for that would suggest the medication isn’t targeting the right pathway?”

Your vet won’t be able to run a gene test on your dog at home, but understanding that these drugs work through distinct mechanisms means there are real options if the first choice doesn’t work out.

Study Limitations Worth Knowing

This study has important boundaries. The 16 dogs were healthy research beagles, not dogs with active allergic skin disease. The allergy-like responses were induced in a controlled research setting, not observed in real patients with naturally occurring allergies. That means the gene-activity patterns seen here may not perfectly mirror what happens in dogs with chronic skin allergies at home.

The sample size of 16 dogs is also relatively small. And because this is a transcriptomic (gene-level) study, it tells us about molecular mechanisms — not whether one drug leads to better itch relief or fewer side effects in real-world patients. Clinical studies with allergic dogs would be needed to answer those questions.

The Bottom Line

A study in 16 beagles found that both Apoquel (oclacitinib) and prednisolone reduce dog skin allergy gene activity — but through different immune pathways, with prednisolone having a broader suppressive effect. This lab-based finding helps explain why dogs can respond differently to each drug and why vets may switch between them.

If your dog is being treated for skin allergies, this research is a reminder that allergy medication is not one-size-fits-all. If the current treatment isn’t working well, there may be a sound scientific reason to try a different approach. Work with your vet to find the medication that fits your dog’s individual needs.


This article summarizes peer-reviewed research for educational purposes. Always consult with your veterinarian for personalized advice about your pet’s health and behavior.

Reference

Oclacitinib and Steroids Calm Dog Skin Allergy Through Different Gene Pathways. (2026). Veterinary Sciences. DOI: https://doi.org/10.3390/vetsci13070676